UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
Notice of Effectiveness
Effectiveness Date:
November 17, 2021
Accession Number:
0001193125-21-325273
Submission Type:
POS AM
CIK:
0001805387
Company Name:
Cerevel Therapeutics Holdings, Inc.
File Number:
333-250964